Cosmos Health Inc COSM 深 沪
交易中 03-31 10:46:39 美东时间
0.3304
+0.004
+1.29%
华盛通- 最 高0.3304
- 今 开0.3192
- 成交量 1.38万股
- 最 低 0.3122
- 昨 收 0.3262
- 总市值 1233.91万
- 52周最高 1.32
- 市盈率 静 --
- 换手率 0.04%
- 52周最低 0.2801
- 委 比 -66.67%
- 总股本 3734.60万
- 历史最高 23.84
- 量 比 0.64
- 振 幅 5.58%
- 历史最低 0.2801
- 每 手 1
- 风险率 0.24%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cosmos Health Reports Record Revenue And Operating Metrics; Projects $12M Annualized U.S. NOOR Collagen Sales With 75% Gross Margins, Pursues U.S. Expansion And M&A Pipeline Including $11.5M Pharmacy Network Acquisition; Holds $18M In Non-Core Assets To Support Strategic Investments; Says Maintains Strong Growth Despite Geopolitical Turmoil; Plans To Issue Updated 2025 Operational, Strategic, And Financial Guidance Following Q4, FY25 Results
Continues to deliver record revenue and improving operating metricsSignificant expansion in the United States underway, with NOOR and other Sky Premium Life products expected to drive strong profitabilitysupported by
03-20 00:49
快讯 | Cosmos Health Inc：评估非核心资产潜在货币化的可能性
Cosmos Health Inc: Evaluating Potential Monetization of Non-Core Assets
03-20 00:46
快讯 | Cosmos Health Inc：中东战争和近期地缘政治动荡对公司运营影响微乎其微
Cosmos Health Inc: War in Middle East and Recent Geopolitical Turmoil Have Had ...
03-20 00:45
Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000
Cosmos Health Inc. announced a Letter of Intent to acquire a Greek pharmacy distribution network generating approximately €10 million in annual revenue. The acquisition aims to expand CosmoFarm’s distribution footprint and integrate its advanced logistics platform, enhancing operational efficiency and service levels. This transaction aligns with the company’s strategy to achieve a $155.8 million revenue target for 2027 through organic growth and ...
03-10 13:00
Cosmos Health Appoints Dr. Dimitrios Iliopoulos to Advisory Board
Cosmos Health Appoints Dr. Dimitrios Iliopoulos to Advisory Board Cosmos Health Inc. appointed Dr. Dimitrios Iliopoulos to its Advisory Board. He will support the company’s biotechnology initiatives, focusing on AI-driven drug discovery and clinical-stage therapeutic development. Disclaimer: This ne
02-25 01:30
Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board
Cosmos Health Inc., a global healthcare group, has appointed Dr. Dimitrios Iliopoulos to its Advisory Board to support AI-driven drug discovery and therapeutic development. Dr. Iliopoulos, a world-renowned expert in AI and drug development, is the Co-Founder and CEO of Athos Therapeutics, where he developed an AI platform for precision therapeutics. His extensive academic and industry experience includes pioneering work in drug repositioning and ...
02-24 17:30
Cosmos Health's C-Scrub Launches at Tesco in the UK
Cosmos Health's C-Scrub Launches at Tesco in the UK Cosmos Health Inc. announced that its antimicrobial skin cleanser, C-Scrub Wash Chlorhexidine 4%, is now available through Tesco, the UK’s largest retailer, including on Tesco.com. The company said the addition expands C-Scrub’s retail distribution
02-18 23:17
Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026
Cosmos Health Inc. (NASDAQ:COSM), a global healthcare group, participated in World Health Expo Dubai 2026, showcasing its nutraceutical and wellness brands, including Sky Premium Life® and C-Scrub®. The event provided an opportunity to connect with potential partners and advance distribution agreements. CEO Greg Siokas emphasized the company's commitment to expanding its global presence and strengthening strategic relationships.
02-17 16:25
Watching Cosmos Health; Shares See Volume, Zacks Small-Cap Research Gives Stock $4.50 Price Valuation
Initiation of Coverage with $4.50 Per Share ValuationZacks initiated coverage on Cosmos Health and assigned a $4.50 per share valuation based on a discounted cash flow (DCF) analysis, reflecting projected revenue growth,
01-15 00:30
